Clinical Cancer Research Targets Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, C.-F.
Right arrow Articles by Ng, I. O.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C.-F.
Right arrow Articles by Ng, I. O.-L.
Clinical Cancer Research Vol. 10, 4140-4149, June 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Evaluation of Nuclear Factor-{kappa}B, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma

Chun-Fung Chan1, Tai-On Yau1,3, Dong-Yan Jin2, Chun-Ming Wong1, Sheung-Tat Fan3 and Irene Oi-Lin Ng1

Departments of 1 Pathology, 2 Biochemistry, and 3 Surgery, Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong

Purpose: Nuclear factor {kappa}B (NF-{kappa}B) signaling pathway is an important regulating pathway in human diseases and cancers. One of its downstream target genes is urokinase plasminogen activator (uPA), which is involved in cancer invasion and metastasis. The purpose of this study was to evaluate NF-{kappa}B activation, uPA up-regulation, and hepatitis B viral X protein (HBx) expression in human hepatocellular carcinoma (HCC) and to assess their clinicopathological significance.

Experimental Design: We evaluated NF-{kappa}B activation, expression of uPA, and presence of HBx in 32 human HCCs. Their clinicopathological significance was assessed by correlation with the clinicopathological features. Aberrant NF-{kappa}B signaling pathway and uPA up-regulation mediated by HBx were also analyzed in vitro.

Results: We found that NF-{kappa}B activation and uPA up-regulation were frequently (56% and 59%, respectively) observed in HCCs, and particularly in HBx-positive HCCs. NF-{kappa}B activation and uPA overexpression were closely associated with one another (P < 0.0001). Furthermore, both activation of NF-{kappa}B and up-regulation of uPA were significantly associated with a more aggressive tumor behavior in terms of venous invasion, direct liver invasion, and absence of tumor encapsulation. In vitro, NF-{kappa}B activation was induced by HBx transfection in HepG2 cells through inhibitor of nuclear factor-{kappa}B kinase ß (IKKß). HBx also up-regulated uPA and enhanced cell invasion synergistically with IKKß.

Conclusions: The data indicate that NF-{kappa}B dysregulation and uPA overexpression may lead to a more aggressive tumor behavior in HCC. In addition, our data suggest that IKKß plays a critical role in the HBx-activated NF-{kappa}B signaling pathway.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. K. Lee, R. T.P. Poon, J. Y. Wo, S. Ma, X.-Y. Guan, J. N. Myers, P. Altevogt, and A. P.W. Yuen
Lupeol Suppresses Cisplatin-Induced Nuclear Factor-{kappa}B Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model
Cancer Res., September 15, 2007; 67(18): 8800 - 8809.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
N H Park, I H Song, and Y-H Chung
Chronic hepatitis B in hepatocarcinogenesis.
Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Ueno, D. Aoki, F. Kubo, K. Hiwatashi, K. Matsushita, T. Oyama, I. Maruyama, and T. Aikou
Roxithromycin Inhibits Constitutive Activation of Nuclear Factor {kappa}B by Diminishing Oxidative Stress in a Rat Model of Hepatocellular Carcinoma
Clin. Cancer Res., August 1, 2005; 11(15): 5645 - 5650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.